Strategic Partnerships Manager

at  Abbott Laboratories

Abbott is a global healthcare leader that helps people live more fully at all stages of life. Our portfolio of life-changing technologies spans the spectrum of healthcare, with leading businesses and products in diagnostics, medical devices, nutritionals and branded generic medicines. Our 109,000 colleagues serve people in more than 160 countries.
Connect with us at www.abbott.com, on LinkedIn at www.linkedin.com/company/abbott-/, on Facebook at www.facebook.com/Abbott and on Twitter @AbbottNews and @AbbottGlobal.
In Germany, Abbott has more than 3,000 employees working in manufacturing, research and development, logistics, sales and marketing. They are located at Abbott`s German headquarters in Wiesbaden and its sites in Hanover, Neustadt am Rübenberge, Wetzlar, Eschborn, Witten, Cologne and Jena. Abbott Automation Solutions in Hamburg (formerly GLP Systems) is now Abbott.
Abbott Diabetes Care Division is looking for a

• Support the ADC EMEAP Strategic Partnerships Manager to select potentially interesting partners, prepare business cases and any required internal documentation to obtain approval to work on a co-operation
• Work with Senior Strategic Partnerships Manager, global business development and the legal department on negotiation of EMEAP-wide term sheets and contracts with partners
• Act as point of contact for all internal stakeholders (partner, global BD, EMEAP marketing & commercial, EMEAP affiliates), where marketing remains responsible for co-promotion partnerships
• Liase with external business partners throughout the whole selection, negotiation and implementation phase
• Develop and implement selling framework to foster adoption of existing and new data interface capabilities
• Consult EMEAP affiliates if they seek to establish local partnerships, share best practices on contracting and negotiating with partners
• Continuously monitor the market for trends that might become relevant for the Diabetes market or that competition is implementing; analyse these findings and provide recommendations to the EMEAP leadership team on how to handle such trends for Abbott Diabetes Care